Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2026-01-04 @ 3:45 AM
Study NCT ID:
NCT01561456
Status:
COMPLETED
Last Update Posted:
2013-12-05
First Post:
2012-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
Sponsor:
Axelar AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AXL-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None